Published in Clin Rheumatol on March 01, 2011
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. Clin Rheumatol (2013) 0.94
[Diagnosis and therapy of early psoriatic arthritis]. Z Rheumatol (2012) 0.90
The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection. Clin Rheumatol (2014) 0.87
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: a long-term follow-up study. Biologics (2012) 0.82
Simple clinical indicators for early psoriatic arthritis detection. Springerplus (2014) 0.79
Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies. BMC Musculoskelet Disord (2014) 0.78
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies. Ther Adv Chronic Dis (2015) 0.76
[Psoriasis-arthritis]. Orthopade (2013) 0.75
Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders. Open Access Rheumatol (2017) 0.75
Efficacy of tocilizumab in a patient with refractory psoriatic arthritis. Clin Rheumatol (2014) 0.75
Joint count reliability in psoriatic arthritis observational trials--an unreported problem. Rheumatology (Oxford) (2012) 0.75
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate. Clin Rheumatol (2017) 0.75
Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum (2006) 10.39
Risk of myocardial infarction in patients with psoriasis. JAMA (2006) 9.42
Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) (2006) 3.73
Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum (2006) 2.67
Early psoriatic arthritis: the clinical spectrum. J Rheumatol (2007) 1.79
Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) (2010) 1.77
Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol (1994) 1.57
The Roche Rheumatology Prize Lecture. The optimal management of early rheumatoid disease: the key to preventing disability. Br J Rheumatol (1994) 1.33
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors. Ann Rheum Dis (2006) 1.32
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology (Oxford) (2008) 1.12
Outcome measures in psoriatic arthritis. J Rheumatol (2007) 1.05
Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis. Rheumatology (Oxford) (2007) 1.01
Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol (1992) 1.00
Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment. Eur J Clin Microbiol Infect Dis (2008) 0.96
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. Clin Rheumatol (2007) 0.94
Psoriatic arthritis from Wright's era until today. J Rheumatol Suppl (2009) 0.91
Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis. Ann Rheum Dis (2008) 0.91
Aspects of early arthritis. Biological therapy in early arthritis--overtreatment or the way to go? Arthritis Res Ther (2007) 0.86
Towards international guidelines for the management of psoriatic arthritis. J Rheumatol (2006) 0.84
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum (2005) 3.31
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol (2012) 2.18
Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. J Hepatol (2008) 2.00
Early psoriatic arthritis: the clinical spectrum. J Rheumatol (2007) 1.79
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis (2013) 1.74
Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology (Oxford) (2009) 1.60
Consensus on a core set of domains for psoriatic arthritis. J Rheumatol (2007) 1.60
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol (2011) 1.52
Serum amyloid-A in Behçet's disease. Clin Rheumatol (2014) 1.47
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? Arthritis Care Res (Hoboken) (2012) 1.46
Qualifying unmet needs and improving standards of care in psoriatic arthritis. Arthritis Care Res (Hoboken) (2014) 1.43
An unusual cause of dysphagia. J Rheumatol (2012) 1.38
Retracted Drug-induced lupus erythematosus. Autoimmunity (2005) 1.31
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum (2008) 1.30
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken) (2013) 1.29
Ileal pouchitis-related arthritis. Semin Arthritis Rheum (2002) 1.23
Enthesitis. Best Pract Res Clin Rheumatol (2006) 1.21
Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol (2006) 1.19
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis (2012) 1.15
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum (2007) 1.07
Outcome measures in psoriatic arthritis. J Rheumatol (2007) 1.05
The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum (2007) 1.04
Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis. Curr Rheumatol Rep (2009) 1.03
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum (2009) 1.02
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis (2010) 1.02
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study. Clin Rheumatol (2011) 1.02
Hepatitis C virus-related arthritis. Autoimmun Rev (2008) 1.02
The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study. J Rheumatol (2011) 1.01
New approaches in the treatment of Adamantiades-Behçet's disease. Curr Opin Rheumatol (2006) 1.01
Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol (2006) 1.00
Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum (2004) 0.98
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome. Int J Rheum Dis (2013) 0.98
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. Clin Rheumatol (2010) 0.97
Efficacy of infliximab in resistant psoriatic arthritis. Arthritis Rheum (2003) 0.96
Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol (2009) 0.96
Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period. Ann Rheum Dis (2007) 0.95
Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study. Arthritis Rheum (2006) 0.95
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients. Clin Rheumatol (2014) 0.94
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. Clin Rheumatol (2013) 0.94
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. Rheumatology (Oxford) (2013) 0.94
Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab. Clin Exp Rheumatol (2011) 0.94
Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series. Dermatology (2014) 0.94
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. Clin Rheumatol (2007) 0.94
The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol (2014) 0.93
Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis. J Rheumatol (2005) 0.92
Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine (2010) 0.92
Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol (2002) 0.91
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome. Clin Rheumatol (2014) 0.91
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol (2013) 0.91
New developments in magnetic resonance imaging of the nail unit. J Rheumatol Suppl (2012) 0.91
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for Rheumatology. Clin Exp Rheumatol (2011) 0.90
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum (2004) 0.89
Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World J Gastroenterol (2009) 0.89
Validation of an extension of the international non-invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis. J Gastroenterol Hepatol (2011) 0.89
The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection. Clin Rheumatol (2014) 0.87
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review. J Rheumatol (2008) 0.87
The challenge of early diagnosis of psoriatic arthritis. J Rheumatol (2008) 0.87
Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study. J Rheumatol (2003) 0.87
The immunology of rheumatoid arthritis. Ann N Y Acad Sci (2007) 0.87
Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. Rheumatology (Oxford) (2009) 0.87
Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers. Joint Bone Spine (2012) 0.87
Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: back to square one. Rheumatology (Oxford) (2012) 0.87
Ultrasound and magnetic resonance imaging in the evaluation of psoriatic dactylitis: status and perspectives. J Rheumatol (2013) 0.86
Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. Medicine (Baltimore) (2016) 0.86
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis. J Rheumatol (2009) 0.86
Prevention of tuberculosis in patients taking tumor necrosis factor-alpha blockers. J Rheumatol Suppl (2009) 0.86
Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritis. J Rheumatol Suppl (2012) 0.86
Vascular endothelial growth factor gene polymorphisms in Behçet's disease. J Rheumatol (2004) 0.86
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study. Rheumatology (Oxford) (2010) 0.85